Torkel Gren, PhD, is Senior Director, Technology Officer & Strategic Investments, at Recipharm. He holds degrees in Pharmacy and Business Administration, as well a PhD in Pharmaceutics from Uppsala University (Sweden). He has worked in the pharmaceutical industry since 1988 and has held a number of scientist and manager positions in Europe and the US. He was lead formulator and co-inventor of Detrol OD/Detrusitol SR (tolterodine, Pfizer). Dr Gren is Vice Chairman of the Board of the Swedish Pharmaceutical Society and Board Director of SwedenBio.